John Lewicki
Vermögen: 31 932 $ am 31.05.2026
Vermögen: 31 932 $ am 31.05.2026
John A. Lewicki is Chief Scientific Officer at Mereo BioPharma Group Plc since 2020.
Formerly, Dr. Lewicki was President, Chief Executive Officer & Director at Mereo BioPharma 5, Inc. from 2018 to 2019.
Prior to that, Dr. Lewicki was Principal at Scios, Inc. from 1983 to 2000.
Dr. Lewicki earned a doctorate from the University of California San Diego.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.02.2026 | 464’130 ( 0.06% ) | 31 932 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Vorstandsvorsitzender | 23.04.2019 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Mereo BioPharma 5, Inc.
Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen